Literature DB >> 24336756

Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.

Christopher A Czaja1, Patricia A Merkel, Edward D Chan, Laurel L Lenz, Molly L Wolf, Rafeul Alam, Stephen K Frankel, Aryeh Fischer, Shaila Gogate, Carlos M Perez-Velez, Vijaya Knight.   

Abstract

An acquired immune deficiency due to interferon gamma (IFN-γ) autoantibodies was diagnosed in a 78-year-old Japanese man with treatment-refractory disseminated nontuberculous mycobacterial infection. In addition to standard antimycobacterial therapy, he was successfully treated with rituximab to eliminate B cells and thereby the autoantibody. Subsequently, he obtained a sustained remission from infection.

Entities:  

Keywords:  immune deficiency; interferon gamma; nontuberculous mycobacteria; rituximab

Mesh：

Substances：

Year:  2013        PMID： 24336756      PMCID： PMC3935498          DOI： 10.1093/cid/cit809

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Authors:  Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity.

Authors:  P Chetchotisakd; P Mootsikapun; S Anunnatsiri; K Jirarattanapochai; C Choonhakarn; A Chaiprasert; P N Ubol; L J Wheat; T E Davis
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

Review 3.  Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.

Authors:  T Kampitak; G Suwanpimolkul; S Browne; C Suankratay
Journal:  Infection       Date:  2010-12-03       Impact factor: 3.553

4.  Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.

Authors:  Smita Y Patel; Li Ding; Margaret R Brown; Larry Lantz; Ted Gay; Stuart Cohen; Lenna A Martyak; Bernard Kubak; Steven M Holland
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection.

Authors:  Chih-Yu Chi; Chen-Chung Chu; Jing-Pei Liu; Chia-Hao Lin; Mao-Wang Ho; Wen-Jyi Lo; Po-Chang Lin; Hung-Jen Chen; Chia-Huei Chou; Jia-Yih Feng; Chang-Phone Fung; Yuh-Pyng Sher; Chi-Yuan Li; Jen-Hsien Wang; Cheng-Lung Ku
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

6.  Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity.

Authors:  Rainer Döffinger; Matthew R Helbert; Gabriela Barcenas-Morales; Kun Yang; Stephanie Dupuis; Lourdes Ceron-Gutierrez; Clara Espitia-Pinzon; Neil Barnes; Graham Bothamley; Jean-Laurent Casanova; Hilary J Longhurst; Dinakantha S Kumararatne
Journal:  Clin Infect Dis       Date:  2003-12-04       Impact factor: 9.079

7.  Adult-onset immunodeficiency in Thailand and Taiwan.

Authors:  Sarah K Browne; Peter D Burbelo; Ploenchan Chetchotisakd; Yupin Suputtamongkol; Sasisopin Kiertiburanakul; Pamela A Shaw; Jennifer L Kirk; Kamonwan Jutivorakool; Rifat Zaman; Li Ding; Amy P Hsu; Smita Y Patel; Kenneth N Olivier; Viraphong Lulitanond; Piroon Mootsikapun; Siriluck Anunnatsiri; Nasikarn Angkasekwinai; Boonmee Sathapatayavongs; Po-Ren Hsueh; Chi-Chang Shieh; Margaret R Brown; Wanna Thongnoppakhun; Reginald Claypool; Elizabeth P Sampaio; Charin Thepthai; Duangdao Waywa; Camilla Dacombe; Yona Reizes; Adrian M Zelazny; Paul Saleeb; Lindsey B Rosen; Allen Mo; Michael Iadarola; Steven M Holland
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

8.  Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex.

Authors:  Toshiyuki Koya; Chikako Tsubata; Hiroshi Kagamu; Ken-ichi Koyama; Masachika Hayashi; Katsuhiro Kuwabara; Takui Itoh; Yoshinari Tanabe; Toshinori Takada; Fumitake Gejyo
Journal:  J Infect Chemother       Date:  2009-04-25       Impact factor: 2.211

9.  Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.

Authors:  Conny Höflich; Robert Sabat; Simone Rosseau; Bettina Temmesfeld; Hortense Slevogt; Wolf-Dietrich Döcke; Gerald Grütz; Christian Meisel; Elke Halle; Ulf B Göbel; Hans-Dieter Volk; Norbert Suttorp
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

10.  Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.

Authors:  Beate Kampmann; Cheryl Hemingway; Alick Stephens; Robert Davidson; Anna Goodsall; Suzanne Anderson; Mark Nicol; Elisabeth Schölvinck; David Relman; Simon Waddell; Paul Langford; Brian Sheehan; Lynn Semple; Katalin A Wilkinson; Robert J Wilkinson; Stanley Ress; Martin Hibberd; Michael Levin
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808
View more
  32 in total

1.  Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody.

Authors:  Yusuke Koizumi; Takuro Sakagami; Naoya Nishiyama; Jun Hirai; Yuta Hayashi; Nobuhiro Asai; Yuka Yamagishi; Hideo Kato; Mao Hagihara; Daisuke Sakanashi; Hiroyuki Suematsu; Kenji Ogawa; Hiroshige Mikamo
Journal:  J Clin Immunol       Date:  2017-08-05       Impact factor: 8.317

2.  Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.

Authors:  Leif G Hanitsch; Madlen Löbel; Holger Müller-Redetzky; Mariana Schürmann; Norbert Suttorp; Nadine Unterwalder; Ulrike Mönnich; Christian Meisel; Kirsten Wittke; Hans-Dieter Volk; Carmen Scheibenbogen; Uwe Kölsch
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

3.  Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.

Authors:  Gloria H Hong; Ana M Ortega-Villa; Sally Hunsberger; Ploenchan Chetchotisakd; Siriluck Anunnatsiri; Piroon Mootsikapun; Lindsey B Rosen; Christa S Zerbe; Steven M Holland
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

Review 4.  An Update on the Use of Immunomodulators in Primary Immunodeficiencies.

Authors:  Pandiarajan Vignesh; Amit Rawat; Surjit Singh
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

5.  Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.

Authors:  Kazutaka Yoshizawa; Ami Aoki; Kenjiro Shima; Yoshinari Tanabe; Toshiyuki Koya; Takashi Hasegawa; Toshiaki Kikuchi; Takuro Sakagami
Journal:  J Clin Immunol       Date:  2020-02-07       Impact factor: 8.317

Review 6.  Nontuberculous mycobacteria infections in immunosuppressed hosts.

Authors:  Emily Henkle; Kevin L Winthrop
Journal:  Clin Chest Med       Date:  2014-12-23       Impact factor: 2.878

Review 7.  [Nontuberculous mycobacterial infections].

Authors:  A Nowag; M Platten; G Plum; P Hartmann
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

Review 8.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 9.  Minireview: Insights into anti-interferon-γ autoantibodies.

Authors:  Kriangkrai Chawansuntati; Kritsadee Rattanathammethee; Jiraprapa Wipasa
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-11

10.  Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Authors:  Donald C Vinh; Laurent Abel; Paul Bastard; Matthew P Cheng; Antonio Condino-Neto; Peter K Gregersen; Filomeen Haerynck; Maria-Pia Cicalese; David Hagin; Pere Soler-Palacín; Anna M Planas; Aurora Pujol; Luigi D Notarangelo; Qian Zhang; Helen C Su; Jean-Laurent Casanova; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-06-08       Impact factor: 8.542
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.